Diverse Biotech
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3805 Old Easton Rd, Doylestown, Pennsylv...Phone Number
(407) 776-9217Website
www.diversebiotech.comRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Diverse Biotech
Diverse Biotech is dedicated to transforming the future of medicine by developing innovative, life-saving therapies for patients and healthcare professionals. The company focuses on addressing critical unmet needs in drug development, particularly for conditions like glioblastoma. With a team of experienced scientists, Diverse Biotech aims to challenge the status quo in pharmaceutical innovation. They are actively seeking strategic partners and investors to advance their clinical programs and expand their platform.Explore more
Diverse Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Diverse Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Diverse Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Diverse Biotech recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Diverse Biotech
Funding: Get notified immidiatlly once Diverse Biotech has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Diverse Biotech launches new products
Click to see if Diverse Biotech had a recent Job posting/layoffs
Check if Diverse Biotech has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Diverse Biotech is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Diverse Biotech as Masked Content
Find 3 more new buyers
Compare Similar Companies to Diverse Biotech
Compare insights from companies similar to Diverse Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Diverse Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Diverse Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Diverse Biotech.
Diverse Biotech Tech Stack
A closer look at the technologies used by Diverse Biotech
See more technologies
Diverse Biotech News & Media
Diverse Biotech Granted Patent for Groundbreaking Multifunctional Conjugate Molecules Targeting Cancer Therapy
This second patent dramatically expands the scope of the company’s intellectual property, encompassing antibody- and beta lactam-based therapeutic molecules. MIAMI, FLORIDA, UNITED STATES, July 22, 2024 /EINPresswire.com/ -- Diverse Biotech, a leader in …Diverse Biotech Announces New Patent Approval for Its PEMBROLIZUMAB Antibody Drug DBT-50201
MIAMI--(BUSINESS WIRE)-- #CBD--Diverse Biotech has been granted USPTO patent approval of its novel CUSP synthesis platform creating an entirely new class of drugs that are part-antibody and part-cannabinoid in one new molecule. Starting with DBT-50201, its novel PEMBROLIZUMAB compound, Diverse expects to develop multiple treatments for many diseases with highly unmet needs. According to John Patrick, M.D., Executive Vice President and Chief Medical Officer for Diverse Biotech, “We are very excitDiverse Biotech Announces Its DBT-12733 Molecule Demonstrated to Be Up to 8,000 Times More Effective Than Temozolomide for Brain Cancer
DOYLESTOWN, Pa.--(BUSINESS WIRE)-- #CBD--Diverse Biotech Announces its DBT-12733 Molecule Demonstrated to be Up to 8,000 Times More Effective Than Chemotherapy Temozolomide for Brain CancerDiverse Biotech announces Strategic Transaction with Enveric Biosciences
ORLANDO, Fla., March 16, 2021 /PRNewswire/ -- Diverse Biotech, Inc. www.diversebiotech.com announced today that it has finalized a strategic transaction with Enveric Biosciences to license exclusive worldwide development and commercialization rights for five novel compounds to address the...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Diverse Biotech
Sign Up For FreeTo access detailed company insights
Diverse Biotech is dedicated to transforming the future of medicine by developing innovative, life-saving therapies for patients and healthcare professionals. The company focuses on addressing critical unmet needs in drug development, particularly for conditions like glioblastoma. With a team of experienced scientists, Diverse Biotech aims to chall... Read More
